ARCHIVES

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

This article is from The Cancer Letter archive.

Vol. 25 No. 45 | November 26, 1999

Download PDF Visit The Full Archive

Related Articles

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011

Also in this 8-page Issue: Safety Warnings Are Added to Labels for Epo and Avastin.

January 21, 2005

Also in this 8-page issue: M.D. Anderson Cancer Center wins ninth SPORE grant, this time for melanoma research.

October 22, 2004

Senate Passes Budget; Broder; Fiscal 93 Great Year – Not

September 25, 1992

Funding Opportunities: NCI Offers Grant Supplements

March 5, 1999

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000